SAN FRANCISCO, Aug. 23, 2022 /PRNewswire/ -- The global fractional flow reserve market size is expected to reach USD 1.81 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.5% from 2022 to 2030. The widening proliferation of cardiovascular diseases coupled with mounting cases of diabetes in developed as well as developing economies is escalating the growth of the market. Furthermore, the launch of novel devices in the fractional flow reserve (FFR) market such as guidewires and monitoring systems are also anticipated to aid market growth. For instance, in May 2019, Philips launched the IntraSight interventional applications platform. This platform offers a comprehensive unit of IVUS, FFR, IFR, and co-registration modalities to speed up routine procedures and simplify complex interventions.
Key Industry Insights & Findings from the report:
- FFR monitoring systems accounted for a significant share of over 41.0% in 2021 owing to the extensive usage in single and multiple vessel CAD.
- FFR guidewires are expected to advance at a profitable rate during the forecast period due to an increase in fractional flow reserve procedures conducted globally.
- Single-vessel coronary artery disease dominated the market with a share of over 50% in 2021, owing to the wide application of the device in CAD, coupled with the rise in the geriatric population.
- North America held a significant share of the FFR industry as of 2021, due to the increased investment in R&D by the medical device companies and the presence of a well-developed healthcare infrastructure.
- Asia Pacific regional FFR industry is anticipated to witness major growth due to rising healthcare spending and a rise in diabetes cases in countries such as China and India.
- The industry participants are engaged in extensive research activities to develop novel FFR devices for the diagnosis of cardiac disorders.
- In July 2021, HeartFlow proclaimed it is merging with Longview Acquisition Corp. II, to become a publicly traded corporation. Upon accomplishment of the proposed transaction, the combined corporation will operate as HeartFlow Group Inc.
Read 150-page full market research report for more Insights, "Fractional Flow Reserve Market Size, Share & Trends Analysis Report By Application (Multi-vessel CAD, Single-vessel CAD), By Product (Monitoring Systems, Guidewires), By Region, And Segment Forecasts, 2022 - 2030", published by Grand View Research.
Fractional Flow Reserve Market Growth & Trends
In an independent study by SCAI in 2019, it was observed that FFR possesses the capability to decide the treatment plan for Acute Coronary Syndrome (ACS) which could be either PCI (Percutaneous Coronary Intervention) or CABG (Coronary Artery Bypass Grafting). This is anticipated to help the physicians and provide an effective treatment plan to patients, thereby increasing adoption of the same in the coming five years.
The COVID-19 pandemic is expected to have a positive impact on the market growth owing to growing initiatives by market players, government support, and others. For instance, in July 2020, Acist Medical Systems, Inc., a Bracco Group Corporation, proclaimed the international introduction of the Navvus II rapid exchange FFR microcatheter, a second-generation device for use with the firm's RXi rapid exchange FFR system in percutaneous coronary intervention procedures. Moreover, consolidation activities, such as the acquisition of St. Jude by Abbott in 2017 in order to increase its foothold in the cardiovascular devices market, are likely to keep the market highly competitive and thereby augur well for the overall market growth.
Fractional Flow Reserve Market Segmentation
Grand View Research has segmented the global fractional flow reserve market on the basis of product, application, and region:
Fractional Flow Reserve Market - Product Outlook (Revenue, USD Million, 2017 - 2030)
- FFR Guidewires
- FFR Monitoring Systems
Fractional Flow Reserve Market - Application Outlook (Revenue, USD Million, 2017 - 2030)
- Multi-vessel Coronary Artery Disease
- Single-vessel Coronary Artery Disease
Fractional Flow Reserve Market - Regional Outlook (Revenue, USD Million, 2017 - 2030)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- Turkey
List of Key Players in the Fractional Flow Reserve Market
- Opsens Medical
- Abbott Laboratories
- Boston Scientific
- ACIST Medical Systems
- Koninklijke Philips N.V.
- Opsens, Inc.
- HeartFlow, Inc.
- Siemens Healthineers
- Pie Medical Imaging
- CathWorks
- Medis Medical Imaging Systems BV
Check out more related studies published by Grand View Research:
- Cardiac Catheters & Guidewires Market - The global cardiac catheters and guidewires market size is expected to reach USD 21.32 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 7.4% from 2020 to 2027. Lack of substitutes in the market, increasing incidence of diabetes and cardiovascular diseases across the globe, and launch of new product lines by the key players are the major factors driving the market.
- Patient Monitoring Devices Market - The global patient monitoring devices market size is expected to reach USD 73.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.8% from 2021 to 2028. The growth is attributed to technological advancement in patient monitoring devices as well as the increasing number of hospital admissions globally.
- Guidewires Market - The global guidewires market size is expected to reach USD 2.90 billion by 2025, at a CAGR 6.3% over a forecast period, according to a new report by Grand View Research, Inc. High prevalence of target diseases such as ischemic heart disease, brain aneurysm, and nephrolithiasis coupled with rise in preference for minimally invasive surgical procedures is anticipated to drive the growth. Increase in application of guidewires in neurovascular interventions is also among key factors driving the market.
Browse through Grand View Research's Medical Devices Industry Research Reports.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com
Grand View Compass | Astra ESG Solutions
Follow Us: LinkedIn | Twitter
Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg
SOURCE Grand View Research, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article